SEC Form 4 · accession 0001206386-18-000010
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard M Marsh
Officer — E.V.P., General Counsel
Period of report
Jun 18, 2018
Accepted (ET)
Jun 19, 2018 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 18, 2018 | M | 33,000 | $30.34 | A | 157,197 | D | |
| Common Stock | Jun 18, 2018 | S | 33,000 | $40.00 | D | 124,197 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $30.34 | Jun 18, 2018 | M | 33,000 | D | Sep 15, 2013 | Sep 15, 2019 | Common Stock | 33,000 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.